At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.
Patent # | Description |
---|---|
US-1,002,9035 |
System, method and kit for the collection and processing of amniotic fluid
and placental aspirate Disclosed is a system for the collection, processing and reuse of amniotic fluid and placental aspirate at a C-section site. The system includes a canister... |
US-1,002,9034 |
Drug-eluting articles with improved drug release profiles The present invention relates to drug-eluting articles with multiple polymeric coatings arranged and constructed to provide improved drug release profiles.... |
US-1,002,9033 |
Encapsulated drug compositions and methods of use thereof Various aspects of the present disclosure provide compositions, coatings and implantable devices including a drug and an excipient. In certain embodiments the... |
US-1,002,9032 |
Drug-eluting medical device The present invention relates to a drug-eluting medical device, in particular a balloon for angioplasty catheters with drug elution to prevent the restenosis of... |
US-1,002,9031 |
Bone void filler having sustained therapeutic agent release A bone void filler material is provided that is configured for sustained release of a therapeutic agent. The bone void filler material comprises a biodegradable... |
US-1,002,9030 |
Molded placental tissue compositions and methods of making and using the
same Described herein are molded dehydrated placental tissue compositions, and pharmaceutical compositions thereof. The compositions have numerous medical... |
US-1,002,9029 |
Apparatus and method for electrospinning a Nanofiber coating on surfaces
of poorly conductive three-dimensional... The present invention is directed to a novel method and apparatus for facilitating and improving efficient application of nanofibers to the surface of poorly... |
US-1,002,9028 |
Biomimetic collagen-hydroxyapatite composite material The invention relates to: --a biomimetic collagen-hydroxyapatite composite material comprising an at least partially fibrous collagen scaffold including mature... |
US-1,002,9027 |
Production method for water-absorbing resin composition A water-absorbing resin composition including 100 parts by weight of water-absorbing resin particles and 0.01 to 1 part by weight of additive particles, wherein... |
US-1,002,9026 |
Systems and methods for performing the bacterial disinfection of a fluid
using point radiation sources A system for disinfecting a fluid, including: a flow cell including one or more inlet ports and one or more outlet ports, wherein the flow cell is configured to... |
US-1,002,9025 |
System and method for reducing germs by means of plasma Disclosed is a system for reducing germs by means of plasma. To this end, a piezoelectric transformer is associated with a dielectric film. The peripheral edge... |
US-1,002,9024 |
Handpiece for treating wounds A system for treating, in particular cleansing, wounds with a fluid jet. The system includes a handpiece with a main body with a front end with an emergence... |
US-1,002,9023 |
Theranostic imaging agents and methods of use The present invention provides targeted nanoplex molecules which carry multimodality imaging reporters together with target enzyme inhibitors such as siRNAs and... |
US-1,002,9022 |
Nuclear medicine diagnostic imaging agent Provided is a radioactive labeled compound capable of detecting a secondary mutation of an epidermal growth factor receptor, where the compound is represented... |
US-1,002,9021 |
Polymer, contrast agent for nuclear magnetic resonance analysis or
magnetic resonance imaging using the... As a substance used as a contrast agent for a method of nuclear magnetic resonance analysis or a method of magnetic resonance imaging, a substance with high... |
US-1,002,9020 |
Fullerene compositions Provided herein are fullerene compositions, and methods of preparing fullerene compositions. More particularly, the fullerene compositions include a... |
US-1,002,9019 |
Method for mitigating osteoporosis using metallic gold cluster molecules A therapeutic method for mitigating bone loss. This method includes preparing and administering to animals intraperitoneally or orally a therapeutic agent... |
US-1,002,9018 |
Pyrrolobenzodiazepines and conjugates thereof A compound which is selected from A: A O OO O O O I O NH O O O O O O O O N H N H N H OO OH H O N N OO H N N B: 5 B O OO O O O Br O NH O O O O O O O O N H N H N... |
US-1,002,9017 |
Pretargeted activatable cell penetrating peptide with intracellularly
releasable prodrug Disclosed herein, the invention pertains to methods and compositions that find use in treatment, diagnosis, prognosis and characterization of disease and... |
US-1,002,9016 |
Immunostimulatory compositions and methods of use thereof Lipid conjugates for enhanced delivery of cargo to the lymph nodes are disclosed. The lipid conjugates typically include three domains: a lipophilic domain that... |
US-1,002,9015 |
Hydrogel formulations A polymeric prodrug composition including a hydrogel, a biologically active moiety and a reversible prodrug linker. The prodrug linker covalently links the... |
US-1,002,9014 |
Synthesis of novel asymmetric bow-tie PAMAM dendrimer-based conjugates for
tumor-targeting drug delivery The present disclosure relates to a dendrimer-based conjugate of the formula V.sub.m-D-C-D'-(T-F).sub.n, which is useful for tumor targeting drug delivery. The... |
US-1,002,9013 |
Surfactant-free, water-free formable composition and breakable foams and
their uses A substantially surface active agent-free and foam adjuvant-free composition which includes a hydrophobic solvent, a wax and a propellant. A substantially... |
US-1,002,9012 |
Peptide-mediated intravesical delivery of therapeutic and diagnostic
agents The present invention relates to compositions comprising therapeutic and/or diagnostic anionic agents together with cationic peptides and their use in methods... |
US-1,002,9011 |
Pharmaceutical composition comprising a GLP-1 agonist, an insulin and
methionine A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof, an insulin or/and a pharmacologically tolerable salt thereof,... |
US-1,002,9010 |
Pharmaceutical compositions comprising meloxicam Disclosed herein are compositions comprising an NSAID such as meloxicam in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These... |
US-1,002,9009 |
Process for treating glaucoma A process for treating glaucoma whereby the treatment can be accomplished by the use of medication or by surgery, or both, in order to control or prevent the... |
US-1,002,9008 |
Therapeutic magnetic control systems and contrast agents A system for the physical manipulation of free magnetic rotors in a circulatory system using a remotely placed magnetic field-generating stator is provided. In... |
US-1,002,9007 |
Stabilisation of polypeptides A method for preserving a polypeptide comprising: (a) providing an aqueous solution of (i) the polypeptide, (ii) one or more sugars, and (iii) a compound of... |
US-1,002,9006 |
Vaccine against bovine leukemia virus The invention relates to recombinant bovine leukemia viruses that have an attenuated phenotype and comprise a combination of at least two specific mutations.... |
US-1,002,9005 |
Bivalent swine influenza virus vaccine The present invention relates to an immunogenic composition comprising: a) a modified live H3 virus of swine influenza, and b) a modified live H1 virus of swine... |
US-1,002,9004 |
Bacterial vaccine components and uses thereof Agents, compositions, methods and kits useful for the treatment and diagnosis of Staphylococcal intramammary infection are disclosed. The agents, compositions,... |
US-1,002,9003 |
Methods and materials for treating cancer This document provides methods and materials for treating cancer. For example, methods and materials for identifying antigens and combinations of antigens that... |
US-1,002,9002 |
Methods and compositions for reducing the environmental impact of animal
waste Methods for reducing the environmental impact of animal waste are described. In particular embodiments, the methods comprise administering to an animal an... |
US-1,002,9001 |
Diaspirin crosslinked pegylated hemoglobin PEGylated diaspirin-crosslinked hemoglobin conjugates having high oxygen affinity are described which have enhanced nitrite reductase activity to deliver... |
US-1,002,9000 |
Uses of IL-12 in hematopoiesis Methods for enhancing or stimulating hematopoiesis including the step of administering Interleukin-12 (IL-12) to yield hematopoietic recovery in a mammal in... |
US-1,002,8999 |
PAR-1 based therapeutic conjugates and uses thereof The present invention is directed to a peptide conjugate comprising an alpha-amino protecting moiety, a peptide comprising the amino acid sequence at least 3... |
US-1,002,8998 |
Method for treating an inflammatory disease and/or an autoimmune disease
with a soluble Fc.gamma.RIIb The present invention relates to a method for treating or preventing either one or both of an inflammatory disease and an autoimmune disease in a patient,... |
US-1,002,8997 |
Systems and methods for attracting and trapping brain cancer cells Described herein are systems and methods for attracting and trapping cancer cells at a specific site where focal radiation and/or surgical resection and/or... |
US-1,002,8996 |
Process for the synchronization of ovulation for timed breeding without
heat detection A method for synchronizing ovulation in sows and gilts by a single injection of hormones is disclosed. A hormone, gonadotropin releasing hormone (GnRH),... |
US-1,002,8995 |
Angiotensin II alone or in combination for the treatment of hypotension The present invention relates, inter alia, to a method comprising administering to a subject having high output shock and undergoing treatment with a... |
US-1,002,8994 |
Memory or learning improvement using peptide and other compositions The present invention generally relates to compositions and methods for topical or transdermal delivery, including treatment and prevention of learning and... |
US-1,002,8993 |
Method of reducing titers of antibodies specific for a therapeutic agent The present invention relates, in general, to a method of treating patients undergoing enzyme replacement therapy (ERT) or other therapy involving the... |
US-1,002,8992 |
Methods of treating muscular dystrophy Disclosed herein are .alpha.7.beta.1 integrin modulatory agents and methods of using such to treat conditions associated with decreased .alpha.7.beta.1 integrin... |
US-1,002,8991 |
Composition, and method of using the composition, effective for minimizing
the harmful effects associated with... The present invention relates to a composition, and methods of using the composition, for minimizing the harmful effects associated with alcohol consumption.... |
US-1,002,8990 |
Functional foods and beverages with synergistic properties to promote
homeostasis The present invention provides compositions having synergistic antioxidant properties in the modulation of Toll-like receptor signaling for the promotion of... |
US-1,002,8989 |
Composition comprising Retinol, a precursor or a reaction product of it
and a plant extract from at least one... The invention relates to a (i) Vitamin A, a reaction product, a metabolite or a precursor of it and (ii) a plant extract of chamomile or an active component... |
US-1,002,8988 |
Synthesis of Nuxia oppositifolia nanoparticles Synthesis of Nuxia oppositifolia nanoparticles includes providing an extract of Nuxia oppositifolia, dissolving the extract in alcohol to provide a mixture,... |
US-1,002,8987 |
Cannabis-infused milk The present invention is directed to compositions and methods comprising a cannabis-infused milk. The milk can be used as an oral dosage form for pharmaceutical... |
US-1,002,8986 |
Method for producing ginkgo extracts The present invention relates to an improved multistep method for the production of an extract of Ginkgo biloba leaves for use as a drug. |